A phase III trial-in-progress called REPLATINUM that compares RRx-001 + a platinum doublet to a platinum doublet in third-line or beyond small cell lung cancer.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Washington University in St. Louis, The University of Kansas Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Mississippi Medical Center, Dartmouth–Hitchcock Medical Center, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of Oklahoma, Nebraska Cancer Specialists, AdventHealth Orlando, Rush University Medical Center, Norton Healthcare, Moffitt Cancer Center
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3031389417